The Weekly Roundup: June 26-30

POLL: What Did You Take Away From SDPA Summer 2023?

Click here to answer today's poll.

Recap From the 2023 SDPA Annual Summer Dermatology Conference

If you weren’t able to attend the 2023 Society of Dermatology Physician Assistants (SDPA) Annual Summer Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.

New Educational Campaign Features Fashion Designer with Psoriasis

A new resource to share with patients follows Nina, who shares the mental and emotional toll of psoriasis and how she manages the condition.

FDA Approves Ritlecitinib For Severe Alopecia Areata

Ritlecitinib is the first and only treatment cleared for adolescents with severe alopecia areata.

Frontline Forum Part 3: Exploring Expert Perspectives on the Management of Acne Vulgaris

In part 3 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

Harmful Social Media Skin Care Trends: Viral Doesn’t Mean Safe

With the social media boom, skin care advice is readily available. Unfortunately, some of the information on TikTok is harmful.

The Mainstream Patient: June 26

This week's edition of the Mainstream Patient features stories about barrier repair products for dry skin, face mapping for acne, how to reapply sunscreen over makeup, and more.

AI Code of Conduct a Goal for New Committee of National Academy of Medicine

The 3-year project aims to set national standards for using new levels of computer learning in health care.

Chromhidrosis: A Rare Clinical Finding

In rare cases, chromhidrosis may be associated with underlying medical conditions, such as hyperthyroidism, dermatitis herpetiformis, and multiple myeloma.

Pointers With Portela: Reviewing Micro-Needling, Retinol, and Sunscreen

In this week’s Pointers With Portela, the 208SkinDoc reviews questions from social media about micro-needling, retinol, and sunscreen use.

Current Research Reveals New Treatment Options for Ichthyosis

Research and ongoing clinical trials are giving some hope to those with ichthyosis but for now most people manage their disease symptomatically.

Sandoz Launches Action Plan to Increase Global Biosimilar Access

The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.

Discussing Evolving Research and Treatment Options in Plaque Psoriasis

Five expert dermatology clinicians discuss the changing landscape of plaque psoriasis treatments and research for adult patients.

POLL: What Common Questions Do You Receive About Retinoids?

Click here to answer this week's poll.

Generalized Pustular Psoriasis Education Initiative Will Improve Care for Patients

The American Academy of Dermatology’s new project uses AI to take treatment for individuals with generalized pustular psoriasis to the next level.

FDA Clears Vbeam Pulsed Dye Laser for Pediatric Port Wine Stains, Hemangiomas

The device is now the first of its kind to become available to pediatric patients.

Expert Providers Share Their Thoughts on Artificial Intelligence in Dermatology

Renata Block, PA-C; Raj Chovatiya, MD, PhD; and Zoe Diana Draelos, MD, discuss their optimism and concerns surrounding the increased use of artificial intelligence in dermatology.

Oral Orismilast Shows Clinically Relevant Improvement In Patients With Moderate To Severe Hidradenitis Suppurativa

The OSIRIS open-label study resulted in a reduction of pain and improvement in quality of life for participants.

Using an Investment Adviser or Doing It Yourself: Factors to Consider

Findings from several large studies quantify the value that professional advisers bring to dermatology practices. Learn when to hone in on their expertise and when to take matters into your own hands.

Seal of Acceptance Will Identify Products That Are Safe For Patients With Rosacea

The National Rosacea Society has launched a program to identify skin care and cosmetic products that will not irritate sensitive skin.

Amlitelimab Reaches Phase 2b Primary Endpoint in AD Management

Sanofi’s investigational anti-OX40-ligand monoclonal antibody showed statistically significant improvement in signs and symptoms of AD in adults.

Combination Stem Cell Transplantation, Laser Therapy Efficacious in Vitiligo

The combination of therapies achieved significant efficacy, with researchers noting a higher cure rate than is evident in other therapies for the condition.

Discovering Dermatology Times: June 2023

Learn more about the in-depth topics covered in the June 2023 issue of Dermatology Times®.

Exposure to Wildfire Smoke Causes Increase in Skin Condition Flareups

The ongoing Canadian wildfires are causing poor air quality in the US, which will likely result in more patients seeking help for skin conditions.

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

FDA Black Box Warning and Liability

Any analysis of physician negligence must first begin with a legal description of the elements of negligence.

Discovering Dermatology Times: June 2023 Acne Supplement

Learn more about the in-depth topics covered in the June 2023 Frontline Forum acne supplement of Dermatology Times.

What's Trending in Skin Care: June 2023

Each month, Dermatology Times features a roundup of products trending in skin care. Find out what products are popular for the month of June.